Literature DB >> 363954

A rapid objective method for measuring the yeast opsonisation activity of serum.

R J Levinsky, B A Harvey, S Paleja.   

Abstract

A simple, objective semi-quantitative assay for yeast opsonisation by normal polymorphs has been developed. This depends on electronically counting the number of free unphagocytosed yeast particles on a Coulter counter. The method has been compared with the widely used microscope technique and shows excellent correlation. The sera of 112 unselected school-children gave a distribution curve consistent with 2 peaks; 7 gave values less than 2 S.D.s below the mean confirming the high incidence of this immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 363954     DOI: 10.1016/0022-1759(78)90129-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  21 in total

1.  Deficiency of mannan binding protein--a new complement deficiency syndrome.

Authors:  M W Turner
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.

Authors:  M Super; R J Levinsky; M W Turner
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

4.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

Authors:  M W Turner; C Grant; N D Seymour; B Harvey; R J Levinsky
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

6.  Defective yeast opsonisation of serum in tuberculosis.

Authors:  N M Johnson; M W McNicol; A Kapoor; J E Burton-Kee; J F Mowbray
Journal:  Thorax       Date:  1980-07       Impact factor: 9.139

7.  Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.

Authors:  D M Roberton; N K Dhanjal; R J Levinsky; J F Mowbray; M W Turner
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

8.  Yeast opsonization in newborn infants and its relationship to parental atopy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

9.  Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.

Authors:  V F Larcher; R J Wyke; L R Davis; C E Stroud; R Williams
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

10.  A common congenital immunodeficiency predisposing to infection and atopy in infancy.

Authors:  V F Richardson; V F Larcher; J F Price
Journal:  Arch Dis Child       Date:  1983-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.